New Oxicam Derivatives—Studies of Membrane Interactions, Cytotoxicity, Cyclooxygenase Inhibition and Molecular Docking
Membranes · 01.05.2026 · 16 (5) · 166
DOI: 10.3390/membranes16050166 ↗Kurz gefasst
Fachartikel in der Zeitschrift Membranes, online erschienen am 01.05.2026. Verfasst von Jadwiga Maniewska und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, Faculty of Pharmacy, Wroclaw Medical University, Borowska 211, 50-556 Wroclaw, Poland. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health Poland, Ministry of Health.
Abstract (Originalsprache)
Oxicam derivatives, a class of nonsteroidal anti-inflammatory drugs (NSAIDs), are important scaffolds for developing biologically active compounds. In this study, arylpiperazine oxicam derivatives (PR24–PR50) were examined for membrane interactions, cytotoxic activity, cyclooxygenase inhibition, and potential binding to COX-2 protein. Membrane interactions were examined using differential scanning calorimetry (DSC) in phospholipid bilayers formed from 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC). All compounds altered the thermotropic properties of the lipid bilayer, showing concentration-dependent decreases in phase transition temperature, indicating incorporation to bilayer and partial disruption of lipid organization. Cytotoxicity, assessed using the MTT assay in breast cancer (MCF-7, MCF-7/DX), colorectal cancer (LOVO, LOVO/DX), and normal V79 cell lines, showed moderate effects, particularly against colorectal cancer cells. Cyclooxygenase inhibition was rather weak, with IC50 values in the high micromolar range, indicating limited anti-inflammatory potential compared with reference COX inhibitors, although docking studies suggested possible interactions with the COX-2 active site. The obtained results indicate that the biological activity of the arylpiperazine oxicam derivatives is primarily associated with cytotoxicity and membrane effects rather than COX inhibition. These limitations should be considered in the design of future membrane-targeted bioactive compounds.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicinal Chemistry, Faculty of Pharmacy, Wroclaw Medical University, Borowska 211, 50-556 Wroclaw, Poland.
- Division of Basic Medical Sciences, Department of Basic Medical Sciences and Immunology, Faculty of Pharmacy, Wroclaw Medical University, Borowska 211, 50-556 Wroclaw, Poland.
- Department of Basic Chemical Sciences, Faculty of Pharmacy, Wroclaw Medical University, Borowska 211a, 50-556 Wroclaw, Poland.
ORCID-Profile: Jadwiga Maniewska, Katarzyna Gębczak, Łucja Cwynar-Zając, Żaneta Czyżnikowska, Berenika M Szczęśniak-Sięga
Förderung
- Ministry of Health Poland
- Ministry of Health
Zitieren
APA
Maniewska, J., Gębczak, K., Cwynar-Zając, Ł., Czyżnikowska, Ż., & Szczęśniak-Sięga, B. M. (2026). New Oxicam Derivatives—Studies of Membrane Interactions, Cytotoxicity, Cyclooxygenase Inhibition and Molecular Docking. Membranes, 16(5), 166. https://doi.org/10.3390/membranes16050166
Vancouver
Maniewska J, Gębczak K, Cwynar-Zając Ł, Czyżnikowska Ż, Szczęśniak-Sięga BM. New Oxicam Derivatives—Studies of Membrane Interactions, Cytotoxicity, Cyclooxygenase Inhibition and Molecular Docking. Membranes. 2026;16(5):166. doi:10.3390/membranes16050166
BibTeX
@article{Maniewska2026,
author = {Maniewska, Jadwiga and Gębczak, Katarzyna and Cwynar-Zając, Łucja and Czyżnikowska, Żaneta and Szczęśniak-Sięga, Berenika M},
title = {New Oxicam Derivatives—Studies of Membrane Interactions, Cytotoxicity, Cyclooxygenase Inhibition and Molecular Docking},
journal = {Membranes},
year = {2026},
volume = {16},
number = {5},
pages = {166},
doi = {10.3390/membranes16050166}
}
EUVIMED